Life Healthcare Group Holdings Past Earnings Performance
Past criteria checks 2/6
Life Healthcare Group Holdings's earnings have been declining at an average annual rate of -10.3%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been declining at an average rate of 3.4% per year. Life Healthcare Group Holdings's return on equity is 12.6%, and it has net margins of 5.9%.
Key information
-10.3%
Earnings growth rate
-10.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -3.4% |
| Return on equity | 12.6% |
| Net Margin | 5.9% |
| Next Earnings Update | 20 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Life Healthcare Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 23,761 | 1,410 | 2,327 | 0 |
| 31 Dec 23 | 23,326 | 1,332 | 2,271 | 0 |
| 30 Sep 23 | 22,890 | 1,254 | 2,214 | 0 |
| 31 Mar 23 | 18,078 | 1,225 | 2,916 | 0 |
| 31 Dec 22 | 19,414 | 1,265 | 2,424 | 0 |
| 30 Sep 22 | 20,750 | 1,305 | 1,932 | 0 |
| 31 Mar 22 | 27,621 | 1,544 | 2,332 | 0 |
| 31 Dec 21 | 27,340 | 1,606 | 2,332 | 0 |
| 30 Sep 21 | 27,059 | 1,667 | 2,332 | 0 |
| 31 Mar 21 | 24,595 | 629 | 2,226 | 0 |
| 31 Dec 20 | 24,299 | 668 | 2,226 | 0 |
| 30 Sep 20 | 24,003 | 706 | 2,226 | 0 |
| 30 Jun 20 | 25,006 | 1,860 | 2,296 | 0 |
| 31 Mar 20 | 26,009 | 3,014 | 2,365 | 0 |
| 31 Dec 19 | 25,957 | 2,792 | 2,365 | 0 |
| 30 Sep 19 | 25,904 | 2,569 | 2,365 | 0 |
| 30 Jun 19 | 25,348 | 1,862 | 1,959 | 0 |
| 31 Mar 19 | 24,792 | 1,155 | 1,553 | 0 |
| 31 Dec 18 | 24,254 | 1,365 | 1,553 | 0 |
| 30 Sep 18 | 23,716 | 1,575 | 1,553 | 0 |
| 30 Jun 18 | 23,184 | 1,511 | 1,459 | 0 |
| 31 Mar 18 | 22,652 | 1,447 | 1,365 | 0 |
| 31 Dec 17 | 21,810 | 1,131 | 1,365 | 0 |
| 30 Sep 17 | 20,967 | 814 | 1,365 | 0 |
| 30 Jun 17 | 19,656 | 805 | 1,050 | 0 |
| 31 Mar 17 | 18,345 | 795 | 734 | 0 |
| 31 Dec 16 | 17,456 | 1,206 | 734 | 0 |
| 30 Sep 16 | 16,567 | 1,616 | 734 | 0 |
| 30 Jun 16 | 16,034 | 1,808 | 662 | 0 |
| 31 Mar 16 | 15,500 | 1,999 | 589 | 0 |
| 31 Dec 15 | 15,138 | 1,933 | 589 | 0 |
| 30 Sep 15 | 14,776 | 1,866 | 589 | 0 |
| 30 Jun 15 | 14,379 | 1,830 | 575 | 0 |
| 31 Mar 15 | 13,982 | 1,793 | 560 | 0 |
| 31 Dec 14 | 13,545 | 2,284 | 560 | 0 |
| 30 Sep 14 | 13,107 | 2,774 | 560 | 0 |
| 30 Jun 14 | 12,795 | 2,772 | 529 | 0 |
| 31 Mar 14 | 12,483 | 2,770 | 498 | 0 |
| 31 Dec 13 | 12,197 | 2,241 | 498 | 0 |
Quality Earnings: L53 has high quality earnings.
Growing Profit Margin: L53's current net profit margins (5.9%) are lower than last year (6.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: L53's earnings have declined by 10.3% per year over the past 5 years.
Accelerating Growth: L53's earnings growth over the past year (15.1%) exceeds its 5-year average (-10.3% per year).
Earnings vs Industry: L53 earnings growth over the past year (15.1%) did not outperform the Healthcare industry 30.9%.
Return on Equity
High ROE: L53's Return on Equity (12.6%) is considered low.